Document:

ThermoEnergy
Corporation

Standstill
Agreement

  

Agreement dated as
of February 28, 2014 by and among ThermoEnergy Corporation, a Delaware corporation (the “Company”), The Roenigk Family
Trust dated November 10, 2004 (“Roenigk”), Robert S. Trump (“Trump”) and Empire Capital Partners, LP, Empire
Capital Partners, Ltd., and Empire Capital Partners Enhanced Master Fund Ltd. (collectively, “Empire”). Roenigk, Trump
and Empire are collectively referred to herein as the “Creditors”).

 

Whereas, Roenigk is
the holder of the Company’s Amended and Restated Convertible Promissory Note due March 31, 2014 in the original principal
amount of $1,877,217.12 (the “Roenigk Note”); and

 

Whereas, Trump is the
holder of the Company’s 12% Secured Promissory Note in the original principal amount of $2,000,000.00 (the “Trump Note”);
and

 

Whereas, Empire are
the holders of the Company’s 12% Secured Promissory Notes in the aggregate original principal amount of $2,000,000.00 (the
“Empire Notes” and, together with the Roenigk Note and the Trump Note, the “Notes”); and

 

Whereas, the Company’s
obligations under the Trump Note and the Empire Notes are secured by the pledge of substantially all of the Company’s assets
pursuant to a Security Agreement dated as of August 22, 2013 by and among the Company, Trump and Empire, as the Secured Parties,
and Empire Capital Partners, LP, as Agent for itself and the other Secured Parties (the “Security Agreement”);

 

Now, therefore, for
good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Creditors hereby
agree as follows:

 

1.                 
Forbearance. Notwithstanding the maturity of any of the Notes nor the occurrence or continuation of any Event of Default
under any of the Notes or under the Security Agreement, none of the Creditors shall during the period from the date of this Agreement
through May 1, 2014 (the “Forbearance Period”) commence any enforcement, collection (including judicial or nonjudicial
foreclosure) or similar proceeding with respect to any of the Notes, the Security Agreement or the Collateral (as such term is
defined in the Security Agreement) or exercise any other rights or remedies any of the Creditors may have under the Notes or the
Security Agreement or otherwise, at law or in equity, with respect to the obligations of the Company to the Creditors under the
Notes or the Security Agreement. 

 

2.                 
Non-Waiver. The Creditors waive no rights or remedies they may have under the Notes or the Security Agreement, but merely
agree not to enforce those rights or remedies during the Forbearance Period. Notwithstanding the Creditors’ agreement to
forbear set forth in Section 1 above, the Notes shall continue, during the Forbearance Period, to bear interest in accordance with
their respective terms. Further, Roenigk’s agreement to forbear shall not affect or limit Roenigk’s right during the
Forbearance Period to receive interest payments under the Roenigk Note or to convert the Roenigk Note into shares of the Company’s
Common Stock as provided in the Roenigk Note.

 

    	

    	 

    

 

3.                 
Revocation. Notwithstanding the Creditors’ agreement to forbear set forth in Section 1, if, during the Forbearance
Period, (i) the Company shall apply for or consent to the appointment of a receiver, trustee or liquidator of all or a substantial
part of any of its assets; (ii) the Company shall file or permit the filing of any petition, case arrangement, reorganization,
or the like under any insolvency or bankruptcy law, or the adjudication of it as a bankrupt, or the making of an assignment for
the benefit of creditors or the consenting to any form or arrangement for the satisfaction, settlement or delay of debt or the
appointment of a receiver for all or any part of its properties; or (iii) an order, judgment or decree shall be entered, or a case
shall be commenced, against the Company, without its application, approval or consent by any court of competent jurisdiction, approving
a petition or permitting the commencement of a case seeking reorganization or liquidation of the Company or appointing a receiver,
trustee or liquidator of the Company, or of all or a substantial part of the assets of the Company, and the Company, by any act,
indicate its approval thereof, consent thereto, or acquiescence therein, or such order, judgment, decree or case shall continue
unstayed and in effect for any period of 30 consecutive days or an order for relief in connection therewith shall be entered, then
any of the Creditors may, upon 5 business days’ written notice to the Company and the other Creditors, revoke its agreement
to forbear, whereupon all of the Creditors shall be entitled to exercise in full any and all of their rights under the Notes and
the Security Agreement with respect to any default or Event of Default then existing or thereafter arising.

 

4.                 
Governing Law; Venue. This Agreement and the rights of the parties hereunder shall be construed and enforced in accordance
with the laws of the Commonwealth of Massachusetts applicable to agreements executed and to be performed wholly within such State
and without regard to principles of conflicts of law. Each party irrevocably (a) consents to the jurisdiction of the federal and
state courts situated in or having jurisdiction over Boston, Massachusetts in any action that may be brought for the enforcement
of this Agreement, and (b) submits to and accepts, with respect to its properties and assets, generally and unconditionally, the
in personam jurisdiction of the aforesaid courts, waiving any defense that such court is not a convenient forum. 

 

5.                 
Amendments. This Agreement may be amended only by a written instrument executed by each party hereto.

 

6.                 
Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and
all of which together shall constitute one and the same instrument. Delivery of a counterpart by facsimile or other electronic
transmission shall bind the party making such delivery notwithstanding any subsequent failure or refusal to deliver an original.

 

[The balance of this page has been left
blank intentionally. Signature Page follows.]

 

    	-2-

    	 

    

 

In witness whereof,
the Company and the Creditors have executed this Agreement as of the date first above written.

  

 

	
         

        ThermoEnergy
        Corporation

         

         

        By:   /s/ Gregory M.
        Landegger              

        Gregory M. Landegger

        Chief Operating Officer

        and Interim Chief
        Financial Officer

         
	
         

        Empire Capital Partners,
        lp

        By: Empire gp, llc, its
        General Partner

         

        By:   /s/ Scott A. Fine                    

        Scott A. Fine

        Managing Member

         

        and

         

        By:  /s/ Peter J. Richards               

        Peter J. Richards

        Managing Member

         

	
         

        Empire Capital Partners,
        ltd

        By: Empire Capital Management,
        llc, 

        its Investment Manager

         

         

        By:   /s/ Scott A. Fine                    

        Scott A. Fine

        Managing Member

         

        and

         

        By:  /s/ Peter J. Richards               

        Peter J. Richards

        Managing Member

         
	
         

        Empire
        Capital Partners Enhanced Master Fund, ltd

        By: Empire Capital Management,
        llc, 

        its Investment Manager

         

         

        By:   /s/ Scott A. Fine                    

        Scott A. Fine

        Managing Member

         

        and

         

        By:  /s/ Peter J. Richards               

        Peter J. Richards

        Managing Member

	
         

        The Roenigk Family Trust
        dated November 10, 2004 

         

         

         

         

         

        By:   /s/ Elise C. Roenigk                     

        Elise C. Roenigk

        Trustee

         
	
         

         

         

         

          /s/
        Robert S. Trump                          

        Robert S. Trump

         

 

 

    	-3-THIS NOTE HAS NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE TRANSFERRED UNLESS THE COMPANY HAS RECEIVED
A WRITTEN OPINION FROM COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY STATING THAT SUCH TRANSFER IS BEING MADE IN COMPLIANCE
WITH ALL APPLICABLE FEDERAL AND STATE SECURITIES LAWS.

SEVENTH AMENDED AND RESTATED

PROMISSORY NOTE

 

 

	Frederick, Maryland	 	$1,038,957.94
	February 1, 2014	 	Due: July 31, 2014

  

For value received,
the undersigned, Vaccinogen, Inc., a Maryland corporation (“Maker”), promises to pay to the order of
The Abell Foundation, Inc., a Maryland corporation (“Payee”), at such place as the holder of this Note
may from time to time designate the principal sum of One Million Thirty-Eight Thousand Nine Hundred Fifty-Seven and 94/100 Dollars
($1,038,957.94), together with the interest thereon at the rate hereinafter specified and any and all other sums which may be due
and owing to the holder of this Note in accordance with the following terms:

 

1.Note Issuance. This non-negotiable
promissory note (this “Note”) is issued pursuant to the Note and Warrant Purchase Agreement dated as
of October 26, 2011, between Maker and Payee, as amended by that certain Amendment No. 1 to Note and Warrant Purchase Agreement
February 16, 2012, between Maker and Payee, as further amended by that certain Amendment No. 2 to Note and Warrant Purchase Agreement
dated January 16, 2013, by and between Maker and Payee, as further amended by that certain Amendment No. 3 to Note and Warrant
Purchase Agreement dated April 18, 2013, by and between Maker and Payee, as further amended by that certain Amendment No. 4 to
Note and Warrant Purchase Agreement dated as of May 31, 2013, by and between Maker and Payee, as further amended by that certain
Amendment No. 5 to Note and Warrant Purchase Agreement dated July 31, 2013, by and between Maker and Payee, as further amended
by that certain Amendment No. 6 to Note and Warrant Purchase Agreement dated as of January 1, 2014, by and between Maker and Payee,
and as further amended by that certain Amendment No. 7 to Note and Warrant Purchase Agreement of even date herewith by and between
Maker and Payee (as amended, and as the same may be further amended, supplemented or otherwise modified from time to time, the
“Note and Warrant Purchase Agreement”), and Payee is subject to the terms and entitled to the benefits
of this Note and the Note and Warrant Purchase Agreement and may enforce the agreements of Maker contained herein and therein and
exercise the remedies provided for hereby and thereby or otherwise available in respect hereto and thereto. Capitalized terms used
herein without definition have the meaning assigned thereto in the Note and Warrant Purchase Agreement.

 

    	 

    	 

    

 

2.Payment;
Interest Rate. Subject to the further provisions of this Section 2 and of Section 9, the principal amount under this Note shall
be due and payable on July 31, 2014 (the “Maturity Date”). Simple interest shall accrue from and after
the date of this Note on the principal amount outstanding from time to time at a rate of eight percent (8%) per annum and, together
with all accrued interest under the Existing Note (as hereinafter defined), shall be due and payable on the Maturity Date. Notwithstanding
the foregoing, to the extent necessary to repay the principal amount of this Note in full and all accrued interest thereon, this
Note shall be paid concurrently with the closing of each issuance or sale of additional shares of capital stock, or securities
directly or indirectly convertible or exchangeable for capital stock, of the Company (each an “Equity Issuance”)
occurring after the date hereof in an amount equal to (a) twenty-five percent (25%) of the next $5,693,135 of gross proceeds of
such Equity Issuance(s), and (b) one hundred percent (100%) of the net proceeds of all Equity Issuance(s) thereafter.

 

3.Calculation of Interest.
Interest on this Note shall be calculated on the basis of a 360 day per year factor applied to the actual days on which there exists
an unpaid principal balance due under this Note.

 

4.Application of Payments.
All payments made hereunder shall be applied first to late penalties, costs of collection or other sums owing the holder, then
to accrued interest (including accrued interest under the Existing Note) and last to payment of the principal amount of this Note.

 

5.Prepayment. Maker may
prepay this Note in whole or in part at any time or from time to time without penalty or additional interest, provided that payments
are applied as provided in Section 4 above. Amounts repaid hereunder may not be reborrowed.

 

6.Use of Proceeds. The purpose
of this Note is to fund the working capital needs of Maker, and, by its execution and delivery of this Note, Maker covenants and
agrees that the proceeds of this Note shall be used solely for such purpose. Without limitation of the foregoing, no proceeds of
this Note will be used to purchase or carry any margin stock (within the meaning of Regulation U issued by the Board of Governors
of the Federal Reserve System) or to extend credit to others for the purpose of purchasing or carrying any margin stock.

 

7.Events of Default.
The occurrence of any one or more of the following events (the “Events of Default”) shall constitute
an Event of Default hereunder:

 

(a)any failure by Maker to pay
any principal, interest or other amount due under this Note at or prior to the time when it is due and payable;

 

(b)any failure of Maker to duly
perform, comply with or observe any of the other terms, conditions or covenants contained in this Note or in any of the other Transaction
Documents, if such failure remains uncured for a period of five (5) business days after written notice of such failure is delivered
by Payee;

 

(c)any representation or warranty
made by Maker herein or in any of the other Transaction Documents or in connection therewith, or any information provided by or
on behalf of Maker pursuant hereto or pursuant to any of the other Transaction Documents or in connection therewith, being or becoming
false, misleading, incomplete or incorrect in any material respect;

 

    	-2-

    	 

    

 

(d)Maker (i) defaults
in any payment of principal of or interest on any of its Debt (as defined below) (other than this Note), beyond the period of grace,
if any, provided in the instrument or promissory note under which such Debt was created; or (ii) defaults in the observance or
performance of any other agreement or condition relating to any such Debt or contained in any instrument or agreement relating
thereto, or any other event occurs or condition exists, the effect of which default or other event or condition is to cause, or
to permit the holder(s) of such Debt to cause, with the giving of notice if required, such Debt to become due prior to its stated
maturity;

 

(e)any judgment
against Maker or any attachment or levy against the property of Maker with respect to a claim remains unpaid, unstayed, on appeal,
undischarged, unbonded or undismissed for a period of thirty (30) days;

 

(f)Maker generally
does not pay its debts as such debts become due, or admits in writing its inability to pay its debts generally; or a petition for
relief in a bankruptcy court is filed by Maker; or Maker applies for, consents to or acquiesces in the appointment of a trustee,
custodian or receiver for Maker or any of its assets or property or makes a general assignment for the benefit of its creditors
or, in the absence of such application, consent or acquiescence, a trustee, custodian or receiver is appointed for Maker or for
a substantial part of its assets or property and is not discharged within thirty (30) days hereafter; or any bankruptcy, reorganization,
debt arrangement or other proceeding or case under any bankruptcy or insolvency law or any dissolution or liquidation proceeding
is instituted against Maker and if instituted against Maker is consented to or acquiesced in by Maker or remains undismissed for
sixty (60) days thereafter; or Maker takes any action to authorize any of the actions described in this subsection; or

 

(g)any demand by
a holder of any of the Current Payables (as defined below) to make payment in excess of $30,000 on any Current Payable which remains
unsatisfied by Maker for a period of ten (10) days.

 

“Debt” of any
person means, without duplication, (a) all indebtedness of such person for borrowed money, (b) all obligations of such person to
pay the deferred purchase price of property or services, except trade accounts payable arising in the ordinary course of business,
(c) all obligations of such person evidenced by notes, bonds, debentures or other similar instruments, (d) all obligations of such
person created or arising under any conditional sale or other title retention agreement or arrangement with respect to property
acquired by such person, (e) all obligations of such person as lessee under leases that have been or should be, in accordance with
generally accepted accounting principles, recorded as capital leases, (f) all obligations, contingent or otherwise, of such person
in respect of acceptances, letters of credit or similar extensions of credit, (g) all Debt of others guaranteed directly or indirectly
in any manner by such person, and (h) all Debt of others secured by a lien or other encumbrance on any asset of such person, whether
or not such person has assumed or become liable for the payment of such Debt. Notwithstanding the foregoing, the term “Debt”
shall not include payables of the Maker which are outstanding prior to the date of this Note (whether or not past due) (the “Current
Payables”) including, but not limited to, the amounts owing to Organon Teknika Corporation and Organon BioSciences
International B.V. (and their successors) pursuant to that certain letter agreement dated October 31, 2007.

 

    	-3-

    	 

    

 

8.Default Interest Rate.
Upon the occurrence of an Event of Default until this Note is paid in full, the interest rate applicable to the then outstanding
balance shall be increased to ten percent (10%) upon written notice to Maker by Payee of such Event of Default.

 

9.Rights and Remedies. If
any one or more Events of Default shall occur, then in each and every such case, Payee at its option may at any time thereafter
exercise and/or enforce any or all of the following rights and remedies:

 

(a)declare upon notice to Maker
all of the amounts payable hereunder to be immediately due and payable, whereupon same shall become due and payable, together with
accrued and unpaid interest thereon and all other sums due hereunder, immediately without presentment, demand or protest, all of
which Maker hereby waives, provided that upon the occurrence of an Event of Default described in Section 7(f), all amounts shall
automatically be and become due and payable immediately without any declaration; and

 

(b)bring suit for payment and exercise
any other rights and remedies available to Payee pursuant to this Note, any of the other Transaction Documents or applicable law.

 

CONFESSION OF JUDGMENT.
IF THIS NOTE IS NOT PAID WHEN DUE, MAKER HEREBY IRREVOCABLY AUTHORIZES AND EMPOWERS PAYEE, BY ITS ATTORNEY, OR BY THE PRONOTHARY
OR CLERK OF ANY COURT OF RECORD IN THE STATE OF MARYLAND OR IN ANY JURISDICTION WHERE PERMITTED BY LAW TO BE MAKER’S TRUE
AND LAWFUL ATTORNEY-IN-FACT, AND IN MAKER’S NAME AND STEAD, TO APPEAR FOR MAKER AND CONFESS AND ENTER JUDGMENT AGAINST IT
IN FAVOR OF PAYEE IN ANY JURISDICTION IN WHICH MAKER OR ANY OF ITS PROPERTY IS LOCATED FOR: (i) THE ENTIRE UNPAID PRINCIPAL AMOUNT
OF THIS NOTE THEN REMAINING UNPAID, (ii) INTEREST THEREON THEN ACCRUED AND UNPAID, (iii) ATTORNEYS’ FEES IN THE AMOUNT OF
$10,000, AND (iv) COURT COSTS, WITH OR WITHOUT DECLARATION, WITHOUT STAY OF EXECUTION AND WITH RELEASE OF ALL ERRORS AND THE RIGHT
TO ISSUE EXECUTION FORTHWITH, AND FOR DOING SO THIS NOTE OR A COPY VERIFIED BY AFFIDAVIT SHALL BE A SUFFICIENT WARRANT. MAKER HEREBY
WAIVES AND RELEASES ALL RELIEF FROM ANY AND ALL APPRAISEMENT, STAY OR EXEMPTION LAW OF ANY STATE NOW IN FORCE OR HEREAFTER ENACTED.
THIS AUTHORITY AND POWER SHALL NOT BE EXHAUSTED BY THE EXERCISE THEREOF, AND SHALL CONTINUE UNTIL THE OBLIGATIONS ARE FULLY PAID,
PERFORMED, DISCHARGED AND SATISFIED. IT IS THE INTENTION OF THE PARTIES HERETO THAT THE PROVISONS OF THIS NOTE RELATING TO THE
PAYMENT OF ATTORNEYS FEES SHALL NOT MERGE INTO ANY JUDGMENT ENTERED IN CONNECTION HEREWITH, AND PAYEE SHALL RETAIN THE RIGHT TO
RECOVER FROM MAKER FEES INCURRED IN THE COLLECTION HEREOF WHICH ARE INCURRED AFTER THE ENTRY OF FINAL JUDGMENT ON THIS NOTE. Notwithstanding
the amount of attorneys’ fees for which judgment may be confessed hereunder, by its acceptance hereof Payee agrees to use
reasonable efforts to retain counsel who will charge Payee only for time and expenses at standard hourly rates, and Payee will
not enforce the attorney’s fee portion of any confessed judgment for an amount in excess of the actual fees and expenses
charged to Payee by its counsel in connection with confessing judgment against Maker and collecting on such judgment. (This provision
shall not limit the obligation of Maker to pay all reasonable attorneys’ fees incurred by Payee in connection with this Note.)

 

    	-4-

    	 

    

 

Each right, power and
remedy of Payee specified herein or available at law or in equity or by statute shall be cumulative and concurrent and shall be
in addition to every other right, power or remedy provided for in this Note or available at law or in equity and the exercise or
beginning of the exercise by Payee of any one or more of such rights, powers or remedies shall not preclude the simultaneous or
later exercise by Payee of any or all other rights, powers or remedies.

 

10.Costs of Collection.
If at any time the indebtedness evidenced by this Note is collected through legal proceedings or this Note is placed in the hands
of an attorney or attorneys for collection, Maker hereby agrees to pay all costs and expenses (including attorneys’ fees)
incurred by the holder of this Note in enforcing its rights and collecting or attempting to collect all amounts due hereunder and
under any related documents.

 

11.Extensions or Modifications.
Maker agrees that the maturity of this Note or any payment due hereunder may be extended by Payee at any time or from time to time,
this Note may be modified by Payee, and any defaults hereunder may be waived by Payee without releasing, discharging or affecting
the liability of Maker. No modification or waiver of any provision of this Note, and no consent by Payee to any failure of Maker
to comply with any provision of this Note, shall in any event be effective unless the same shall be in writing signed by Payee.

 

12.Choice of Law; Jurisdiction;
Severability. This Note shall be governed, construed and enforced in strict accordance with the laws of the State of Maryland,
without reference to principles of conflict of laws. Maker agrees that any suit, action or proceeding instituted by Payee with
respect to any of the obligations of Maker hereunder may be brought in any State or federal court located in the State of Maryland
(in addition to such other courts in which jurisdiction and venue may be appropriate), and Maker consents to the in personam
jurisdiction of such courts. If any provision of this Note shall for any reason be invalid or unenforceable, such invalidity or
unenforceability shall not affect any other provision.

 

13.Waiver of Defenses. In
the event the holder of this Note transfers this Note for value, Maker agrees that none of such subsequent holders of this Note
shall be subject to any claims or defenses which Maker may have against the prior holder, all of which are waived as to the subsequent
holders and all subsequent holders shall have the rights of a holder in due course with respect to Maker even though the subsequent
holder might not qualify under applicable law absent this paragraph as a holder in due course.

 

    	-5-

    	 

    

 

14.Waivers. Maker hereby
waives (a) presentment, protest and demand and notice of protest, demand, dishonor and nonpayment of this Note; (b) all claims
and causes of action of Maker against Payee for punitive, exemplary or other non-compensatory damages; and (c) diligence in
the enforcement or collection of all of the obligations of Maker hereunder. EACH OF PAYEE AND MAKER AGREES THAT ANY ACTION, SUIT
OR PROCEEDING INVOLVING ANY CLAIM, COUNTERCLAIM OR CROSS-CLAIM ARISING OUT OF OR IN ANY WAY RELATING, DIRECTLY OR INDIRECTLY, TO
ANY OF THE OBLIGATIONS OF MAKER HEREUNDER SHALL BE TRIED BY A COURT AND NOT BY A JURY, EACH OF PAYEE AND MAKER HEREBY WAIVING ANY
RIGHT TO TRIAL BY JURY IN ANY SUCH ACTION, SUIT OR PROCEEDING AND HEREBY AGREEING THAT THIS WAIVER OF TRIAL BY JURY IS A MATERIAL
ASPECT OF THEIR AGREEMENTS.

 

15.No Waiver; No assignment.
The delay or failure of any holder to exercise its rights hereunder shall not be deemed a waiver thereof. No waiver of any rights
of holder shall be effective unless in writing and signed by the holder and any waiver of any right shall not apply to any other
right or to such right in any subsequent event or circumstance not specifically included in such waiver. Maker may not assign its
rights or obligations under this Note.

 

16.Headings. The headings
used in this Note are used for convenience only and are not to be considered in construing or interpreting this Note.

 

17.Replacement Note. This Note
is given pursuant to the terms of that certain Amendment No. 7 to Note and Warrant Purchase Agreement of even date herewith by
and between Maker and Payee in replacement of the “Note” as defined in the Note and Warrant Purchase Agreement immediately
prior to the date hereof (the “Existing Note”). The execution of this Note and the replacement of the
Existing Note hereby shall not constitute or act as a novation, satisfaction or extinguishment of the indebtedness evidenced by
the Existing Note, and all accrued and unpaid interest under the Existing Note shall be due and payable on the Maturity Date unless
required to be paid prior thereto pursuant to the terms hereof. This Note shall for all purposes be the “Note” as defined
in the Note and Warrant Purchase Agreement and in that certain Security Agreement dated October 26, 2011, by and between Maker
and Payee (the “Security Agreement”), the terms of which are incorporated herein and made a part hereof as if fully
set forth herein. This Note is one of the “Transaction Documents” as defined in the Note and Warrant Purchase Agreement,
and the obligations of Maker hereunder are part of the “Obligations” as defined in the Security Agreement.

 

[THE NEXT PAGE IS THE SIGNATURE PAGE]

 

    	-6-

    	 

    

 

IN WITNESS WHEREOF,
Maker has caused this Note to be executed on its behalf by its duly authorized officer as of the day and year first above written.

 

 

	 	VACCINOGEN,
    INC.
	 	 
	 	 
	 	By:	/s/ Michael G. Hanna, Jr.,
    Ph.D.
	 	Name:	Michael G. Hanna, Jr.,
    Ph.D.
	 	Title:	Chairman and Chief Executive
    Officer
	 	 	 
	 	 	 
	 	By:	/s/ Andrew L. Tussing
	 	Name:	Andrew L. Tussing
	 	Title:	President and Chief Operating
    Officer

  

    	-7-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]